Brief report on a phase I/IIa study to assess the safety, tolerability, and immune response of AGMG0201 in patients with essential hypertension

Added 40 days ago (17.10.2021)
Authors: Hironori Nakagami; Tetsuya Ishihama; Yuichi Daikyoji; Chieka Sasakura; Ei Yamada; Ryuichi Morishita
Read article